You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Autologous Transplant

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial (Isatuximab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Apr 19, 2022

Multiple Myeloma, Relapsed, Multiple Myeloma, Refractory to Standard Treatment Trial in Chicago (radiation, drug, procedure)

Completed
  • Multiple Myeloma, Relapsed
  • Multiple Myeloma, Refractory to Standard Treatment
  • Total Marrow Irradiation
  • +3 more
  • Chicago, Illinois
    University of Illinois Cancer Center
Nov 20, 2021

Autologous Transplant, Myeloma Trial in Cleveland (Mycobiome Supporting Diet)

Not yet recruiting
  • Autologous Transplant
  • Myeloma
  • Mycobiome Supporting Diet
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 22, 2022

Lymphoma, HIV Trial in United States (Autologous transplant, BCNU, Etoposide)

Completed
Has Results
  • Lymphoma
  • HIV
  • Autologous transplant
  • +4 more
  • Duarte, California
  • +15 more
Dec 6, 2022

Multiple Myeloma Trial in Atlanta (BeEAM)

Completed
  • Multiple Myeloma
  • Atlanta, Georgia
    Blood and Marrow Transplant Group of Georgia
Oct 19, 2022

Morbidity, Long-term Side Effects and Quality of Life in

Recruiting
  • Germ Cell Tumor
    • Villejuif, France
      Gustave Roussy
    Jun 2, 2023

    Multiple Myeloma Trial in Atlanta, Chicago (procedure, drug, other)

    Recruiting
    • Multiple Myeloma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +2 more
    • Atlanta, Georgia
    • +1 more
    Feb 25, 2022

    Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Oct 25, 2023

    Neuroblastoma Trial in Minneapolis (drug, biological, radiation)

    Recruiting
    • Neuroblastoma
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Apr 11, 2022

    Plasma Cell Myeloma, Transplant-Related Carcinoma Trial in Seattle (Ixazomib Citrate, Laboratory Biomarker Analysis,

    Active, not recruiting
    Has Results
    • Plasma Cell Myeloma
    • Transplant-Related Carcinoma
    • Ixazomib Citrate
    • +2 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center
    Jul 12, 2022

    Based on Maintenance Therapy Post Autologous Stem Cell

    Recruiting
    • Multiple Myeloma
    • Autologous Stem Cell Transplant
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    Jul 27, 2022

    Large Cell Lymphoma, Diffuse, Relapsed Cancer, Refractory Cancer Trial (AutoSCT, GDP, Epcoritamab)

    Not yet recruiting
    • Large Cell Lymphoma, Diffuse
    • +2 more
    • AutoSCT
    • +2 more
    • (no location specified)
    May 10, 2023

    Distal Amputation of the Fingers Trial in Brest, Quimper (autologous transplant reinjection, desensitization)

    Recruiting
    • Distal Amputation of the Fingers
    • autologous transplant reinjection
    • desensitization
    • Brest, France
    • +1 more
    Jul 12, 2022

    Multiple Myeloma, Amyloidosis Trial in New York (device, drug, procedure)

    Active, not recruiting
    • Multiple Myeloma
    • Amyloidosis
    • Melphalan
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 21, 2022

    Multiple Myeloma Trial in Salt Lake City (Budesonide EC, Placebo)

    Not yet recruiting
    • Multiple Myeloma
    • Budesonide EC
    • Placebo
    • Salt Lake City, Utah
      Huntsman Cancer Institute at the University of Utah
    Jan 9, 2023

    Stem Cell Transplantation Trial in Cairo (conjunctival limbal autologous transplant)

    Recruiting
    • Stem Cell Transplantation
    • conjunctival limbal autologous transplant
    • Cairo, Egypt
      Kasr Alainy
    Aug 9, 2022

    Multiple Myeloma Trial (Elotuzumab, Pomalidomide)

    Withdrawn
    • Multiple Myeloma
    • (no location specified)
    Aug 18, 2021

    Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,

    Recruiting
    • Autoimmune Disease
    • +18 more
    • Anti-Thymocyte Globulin
    • +9 more
    • Denver, Colorado
    • +2 more
    Feb 1, 2023

    Heart Transplantation Trial in Madrid (Autologous thyTreg)

    Recruiting
    • Heart Transplantation
    • Autologous thyTreg
    • Madrid, Spain
      Hospital General Universitario Gregorio Marañon
    Dec 5, 2022

    Systemic Lupus Erythematosus, Systemic Sclerosis Trial in Philadelphia (Depletion of CD3/CD19 in an autologous stem cell

    Recruiting
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Depletion of CD3/CD19 in an autologous stem cell transplant
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    May 23, 2022

    T-Cell Lymphoma Trial in Saint Louis (Duvelisib, Peripheral blood draw)

    Recruiting
    • T-Cell Lymphoma
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jul 18, 2022

    Multiple Myeloma Trial in Boston (CIML NK Cells plus KP1237 and low dose IL-2)

    Recruiting
    • Multiple Myeloma
    • CIML NK Cells plus KP1237 and low dose IL-2
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 18, 2022

    Multiple Myeloma, Stem Cell Transplant Complications Trial in Boston (PARE, Waitlist Control Group)

    Not yet recruiting
    • Multiple Myeloma
    • Stem Cell Transplant Complications
    • PARE
    • Waitlist Control Group
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 30, 2023

    T Cell Lymphoma Trial in Kansas City (Brentuximab Vedotin)

    Withdrawn
    • T Cell Lymphoma
    • Brentuximab Vedotin
    • Kansas City, Kansas
      The University of Kansas Cancer Center, Westwood Campus
    Feb 1, 2023

    Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

    Recruiting
    • Non-Hodgkin Lymphoma
    • Hodgkin Lymphoma
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Jan 25, 2023